Maliszewski CR - Search Results

1

Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.

Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR. Sato TA, et al. Among authors: maliszewski cr. J Immunol. 1993 Apr 1;150(7):2717-23. J Immunol. 1993. PMID: 8454851

2

Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor.

Maliszewski CR, Morrissey PJ, Fanslow WC, Sato TA, Willis C, Davison B. Maliszewski CR, et al. Cell Immunol. 1992 Sep;143(2):434-48. doi: 10.1016/0008-8749(92)90038-q. Cell Immunol. 1992. PMID: 1511483

3

Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.

Maliszewski CR, Sato TA, Vanden Bos T, Waugh S, Dower SK, Slack J, Beckmann MP, Grabstein KH. Maliszewski CR, et al. J Immunol. 1990 Apr 15;144(8):3028-33. J Immunol. 1990. PMID: 2139075

4

Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitro.

Maliszewski CR, Sato TA, Vanden Bos T, Beckmann MP, Grabstein KH. Maliszewski CR, et al. Eur J Immunol. 1990 Aug;20(8):1735-40. doi: 10.1002/eji.1830200817. Eur J Immunol. 1990. PMID: 2145164

5

The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.

Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, Armitage RJ. Grabstein KH, et al. Among authors: maliszewski cr. J Immunol. 1993 Apr 15;150(8 Pt 1):3141-7. J Immunol. 1993. PMID: 7682232

6

In vivo biological effects of recombinant soluble interleukin-4 receptor.

Maliszewski CR, Sato TA, Davison B, Jacobs CA, Finkelman FD, Fanslow WC. Maliszewski CR, et al. Proc Soc Exp Biol Med. 1994 Jul;206(3):233-7. doi: 10.3181/00379727-206-43750. Proc Soc Exp Biol Med. 1994. PMID: 8016157 Review.

7

Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines.

Maliszewski CR, Grabstein K, Fanslow WC, Armitage R, Spriggs MK, Sato TA. Maliszewski CR, et al. Eur J Immunol. 1993 May;23(5):1044-9. doi: 10.1002/eji.1830230510. Eur J Immunol. 1993. PMID: 8097470

8

Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.

Keane-Myers A, Maliszewski CR, Finkelman FD, Nickell SP. Keane-Myers A, et al. Among authors: maliszewski cr. J Immunol. 1996 Apr 1;156(7):2488-94. J Immunol. 1996. PMID: 8786309

9

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Spriggs MK, Koller BH, Sato T, Morrissey PJ, Fanslow WC, Smithies O, Voice RF, Widmer MB, Maliszewski CR. Spriggs MK, et al. Among authors: maliszewski cr. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6070-4. doi: 10.1073/pnas.89.13.6070. Proc Natl Acad Sci U S A. 1992. PMID: 1631092 Free PMC article.

10

CD40L: a multi-functional ligand.

Armitage RJ, Maliszewski CR, Alderson MR, Grabstein KH, Spriggs MK, Fanslow WC. Armitage RJ, et al. Among authors: maliszewski cr. Semin Immunol. 1993 Dec;5(6):401-12. doi: 10.1006/smim.1993.1046. Semin Immunol. 1993. PMID: 7510138 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters